200,000+ products from a single source!

sales@angenechem.com

Home > Sulfanilamide > 3313-26-6

3313-26-6

3313-26-6 | (9Z)-N,N-Dimethyl-9-[3-(4-methyl-1-piperazinyl)propylidene]-9H-thioxanthene-2-sulfonamide

CAS No: 3313-26-6 Catalog No: AG003ASQ MDL No:

Product Description

Catalog Number:
AG003ASQ
Chemical Name:
(9Z)-N,N-Dimethyl-9-[3-(4-methyl-1-piperazinyl)propylidene]-9H-thioxanthene-2-sulfonamide
CAS Number:
3313-26-6
Molecular Formula:
C23H29N3O2S2
Molecular Weight:
443.6253
IUPAC Name:
(9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]thioxanthene-2-sulfonamide
InChI:
InChI=1S/C23H29N3O2S2/c1-24(2)30(27,28)18-10-11-23-21(17-18)19(20-7-4-5-9-22(20)29-23)8-6-12-26-15-13-25(3)14-16-26/h4-5,7-11,17H,6,12-16H2,1-3H3/b19-8-
InChI Key:
GFBKORZTTCHDGY-UWVJOHFNSA-N
SMILES:
CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C
EC Number:
227-001-0
UNII:
7318FJ13YJ
RTECS Number:
XO1400000

Properties

Complexity:
711  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
1  
Exact Mass:
443.17g/mol
Formal Charge:
0
Heavy Atom Count:
30  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
443.624g/mol
Monoisotopic Mass:
443.17g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
77.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.8  

Literature

Title Journal
Network-assisted investigation of antipsychotic drugs and their targets. Chemistry & biodiversity 20120501
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS computational biology 20111201
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals 20101201
In silico prediction of pregnane X receptor activators by machine learning approaches. Molecular pharmacology 20070101
Effect of drug type on the degradation rate of PLGA matrices. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20061101
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Submissive behavior in mice as a test for antidepressant drug activity. Pharmacology, biochemistry, and behavior 20051001
A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR. Journal of medicinal chemistry 20050421
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030301
Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone. Clinical neuropharmacology 20030101
Flow-injection chemiluminometric determination of some thioxanthene derivatives in pharmaceutical formulations and biological fluids using the [Ru(dipy)3(2+)]-Ce(IV) system. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20011101
Metabolites of the antipsychotic agent clozapine inhibit the replication of human immunodeficiency virus type 1. Schizophrenia research 19970503
Fluoxetine and visual hallucinations in dementia. Biological psychiatry 19951015
Neuroleptic-induced extrapyramidal side effects. The American journal of psychiatry 19931101
Esophageal atony and dilatation as a side effect of thiothixene and benztropine. Hospital & community psychiatry 19930701
On the selection of mice for haloperidol response and non-response. Psychopharmacology 19910101
Dropping objects: possible mild cataplexy associated with clozapine. The Journal of nervous and mental disease 19901001
Drug-induced dystonia in young and elderly patients. The American journal of psychiatry 19880701
Manic syndrome associated with zidovudine treatment. JAMA 19880617
Rapid tranquilization: a comparison of thiothixene with loxapine. The Journal of clinical psychiatry 19860601
Neuroleptic-induced catatonia after abrupt withdrawal of amantadine during neuroleptic therapy. Pharmacotherapy 19860101
Akathisia with haloperidol and thiothixene. Archives of general psychiatry 19841101
Drug interactions on spontaneous locomotor activity in rats. Neuroleptics and amphetamine-induced hyperactivity. Neuropharmacology 19840801
Maprotiline hydrochloride associated with a clinical state of catatonic stupor and epileptic encephalogram. Journal of clinical psychopharmacology 19840801
Response to antipsychotic medication: the doctor's and the consumer's view. The American journal of psychiatry 19840101
Desipramine-associated hepatitis. Journal of clinical psychopharmacology 19830801
Neuroleptic malignant syndrome and malignant hyperthermia. Lancet (London, England) 19830129
Bromocriptine associated with symptom exacerbation during neuroleptic treatment of schizoaffective schizophrenia. The Journal of clinical psychiatry 19820601
Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia. The Journal of clinical psychiatry 19820301
Neurotoxicity in patients with schizophrenia during lithium therapy. Comprehensive psychiatry 19820101
Motility, Parkinsonism, and prolactin with thiothixene and thioridazine. Archives of general psychiatry 19810601
Subjective response to antipsychotic drugs. Archives of general psychiatry 19810201
Somnambulistic-like episodes secondary to combined lithium-neuroleptic treatment. The British journal of psychiatry : the journal of mental science 19791101
Cardiovascular side effects of long-term therapy with tricyclic antidepressants in the aged. Journal of the American Geriatrics Society 19790501
Benztropine prophylaxis of dystonic reactions. Psychopharmacology 19790328
Fever, tachycardia, and hypertension with acute catatonic schizophrenia. Archives of internal medicine 19780701
High-dosage and versatile drug therapy with treatment-resistant psychotic patients. Hospital & community psychiatry 19760101
Drug-induced dystonia. The American journal of psychiatry 19750501
Once versus thrice daily thiothixene in the treatment of schizophrenic in-patients. The British journal of psychiatry : the journal of mental science 19740701

Related Products

© 2019 Angene International Limited. All rights Reserved.